Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Newborns With Persistent Pulmonary Hypertension
NCT01409031Phase 2Terminated
- Sponsor
- University of Colorado Denver
- Start
- Jul 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in persistent pulmonary hypertension of the newborn (PPHN), respiratory failure, sponsored by University of Colorado Denver. Started Jul 2011; status: terminated.
02
Drugs
sildenafil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)respiratory failure
Beyond the preview
Go deeper on NCT01409031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01409031.